SCHEMBL6710326

SCHEMBL6710326

O=C(Cc1ccccc1C(F)(F)F)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
PLA2G7 Q13093 1/20 0.39
NHERF1 O14745 1/20 0.38
GRIK1 P39086 1/20 0.38
KMT2A Q03164 3/20 0.38
PYGL P06737 1/20 0.37
GRM5 P41594 1/20 0.36
HTT P42858 1/20 0.36
P2RX4 Q99571 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
PLCG2 P16885 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
STK33 Q9BYT3 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708826 0.91 PLA2G7 (0.39) PLA2G7GRIK1KMT2AHTTMAPT
SCHEMBL6710278 0.90 PARP14 (0.43) GAAPLA2G7NHERF1GRIK1KMT2A
SCHEMBL6707627 0.89 KMT2A (0.46) PLA2G7NHERF1GRIK1KMT2AMAPT
SCHEMBL6711745 0.89 PLA2G7 (0.38) PLA2G7KMT2AHTTRAB9ANPC1
SCHEMBL6710031 0.89 NSD2 (0.41) GAAPLA2G7NHERF1GRIK1KMT2A
SCHEMBL6712250 0.88 P2RY14 (0.41) GRIK1P2RX4MAPTPLCG2
SCHEMBL6713233 0.88 GRIK1 (0.41) PLA2G7NHERF1GRIK1KMT2AMAPT
SCHEMBL6710119 0.87 KDM4E (0.49) GAAKMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL6709861 0.87 GRIK1 (0.41) NHERF1GRIK1KMT2APLCG2SMN1; SMN2
SCHEMBL6707717 0.87 PARP14 (0.44) GRIK1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GAA 111/4885PLA2G7 3314/4885NHERF1 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.